DRKS00022574
Completed
Not Applicable
Drug therapy safety in an interprofessional, geriatric, inpatient complex treatment - TIG
niklinik Köln - Zentrum Innere Medizin0 sites226 target enrollmentNovember 30, 2020
ConditionsGeriatric Syndromes, Geriatric Resources
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Geriatric Syndromes, Geriatric Resources
- Sponsor
- niklinik Köln - Zentrum Innere Medizin
- Enrollment
- 226
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient of ward 17\.1 of the University Hospital Cologne
- •\- Age \= 65 years
- •\- Multimorbidity (\= 2 chronic diseases requiring treatment)
- •\- Patient or proxy able to give consent
- •\- Sufficient knowledge of German
- •\- Degree of care \<4
Exclusion Criteria
- •\- Age \< 65 years
- •\- Lack of multimorbidity (\< 2 chronic diseases requiring treatment)
- •\- Patient or proxy not able to give consent
- •\- Lack of German language skills
- •\- Degree of care \=4
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Interprofessional, risk-adjusted medication management in elderly cancer patientsMalignant diseasesElderly patients over 70 yearsC00-C97Malignant neoplasmsDRKS00021278Pharmazeutisches Institut101
Completed
Not Applicable
Drug therapy safety with patients in facilities of the long-term careAll adverse drug events (ADE)!T88.7Unspecified adverse effect of drug or medicamentDRKS00004952Private Universität Witten/Herdecke gGmbH889
Completed
Not Applicable
Compatibility Problems and Prescribing Pattern of Injectable Drugs at the HospitalIV InjectionNCT04523259National Taiwan University Hospital127
Completed
Not Applicable
Pharmacist-led Intervention for Disease and Risk Management in Patients with Ischemic Heart DiseaseIschemic Heart DiseaseCardiovascular - Coronary heart diseaseACTRN12622000996763Dr. Amjad Khan330
Active, not recruiting
Phase 1
Pediatric PK Study (POS IV and PFS)Prophylaxis of invasive fungal infections in immunocompromised pediatric subjects with neutropenia or expected neutropenia.Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2014-002807-10-CZMerck Sharp & Dohme Corp.84